Thomas Ferguson
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
-
- Renal cell carcinoma treatment 9
- Co-authors
- Nicholas Wilcken (3 shared papers)Anna K. Nowak (5 shared papers)Davina Ghersi (3 shared papers)Melina L Willson (1 shared paper)Lila Zabaglo (1 shared paper)Suzanne C. O’Neill (1 shared paper)Nicholas C. Turner (1 shared paper)Roger A’Hern (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cochrane Database of Systematic Reviews (4 papers)British Journal of Cancer (1 paper)The Lancet Oncology (1 paper)European Urology (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Thomas Ferguson
15 papers receiving 361 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 171
- Oncology 227
- Pulmonary and Respiratory Medicine 133
- Dermatology 23
- Pathology and Forensic Medicine 30
Countries citing papers authored by Thomas Ferguson
This map shows the geographic impact of Thomas Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ferguson more than expected).
Fields of papers citing papers by Thomas Ferguson
This network shows the impact of papers produced by Thomas Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ferguson. The network helps show where Thomas Ferguson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Ferguson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 149 | |
| 2 | 2023 | 73 | |
| 3 | 2019 | 61 | |
| 4 | 2012 | 50 | |
| 5 | 2024 | 22 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2007 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2010 | 2 | |
| 11 | 2018 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2009 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Thomas Ferguson
Thomas Ferguson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 18 papers that have together received 374 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Renal and related cancers (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (171 citations), Oncology (227 citations), Pulmonary and Respiratory Medicine (133 citations), Dermatology (23 citations) and Pathology and Forensic Medicine (30 citations). Thomas Ferguson has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Nicholas Wilcken, Anna K. Nowak, Davina Ghersi, Melina L Willson, Lila Zabaglo, Suzanne C. O’Neill, Nicholas C. Turner, Roger A’Hern, Margaret Hills and Ian Smith. Their work appears in journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews, British Journal of Cancer, The Lancet Oncology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.